[Form 4] CLOROX CO /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Stacey Grier, EVP & Executive Chief of Staff at The Clorox Company (CLX), reported an acquisition of 3,364 restricted stock units on 09/16/2025. The Form 4 shows the units were recorded at a price of $124.85 and, after the transaction, Ms. Grier beneficially owned 23,190 shares. The restricted stock units vest in four equal installments, with one-quarter vesting on each of October 5, 2026, 2027, 2028 and 2029. The filing was signed by an attorney-in-fact on 09/18/2025.

Positive

• Acquisition of 3,364 restricted stock units recorded on 09/16/2025
• Clear multi-year vesting schedule: one-quarter vests on each October 5 in 2026, 2027, 2028 and 2029
• Beneficial ownership updated to 23,190 shares following the reported transaction

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider award of 3,364 RSUs to an executive, vesting over four years, increases reported beneficial ownership to 23,190 shares.

The Form 4 documents a standard equity award to an executive officer rather than a market purchase or sale. The grant size and the disclosed $124.85 price reflect the award's reporting basis; the filing also specifies a staggered vesting schedule across October 2026-2029. For investors tracking insider activity, this is a routine compensation disclosure that updates the officer's reported ownership level.

Corporate Governance Expert

TL;DR: Routine executive compensation disclosure with multi-year vesting; confirms alignment between executive pay and company equity.

The Form 4 indicates the award is restricted stock units with explicit vesting dates and increments, a common governance practice to retain executives and align incentives. The report identifies the reporting person as an officer (EVP - Executive Chief of Staff) and provides the post-grant beneficial ownership total of 23,190 shares. The document is a standard Section 16 disclosure filed by an attorney-in-fact.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Grier Stacey

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP - Executive Chief of Staff

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2025		A(1)		3,364	A	$124.85	23,190	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2026, 2027, 2028 and 2029.

	By Jinho Joo, Attorney-in-Fact	09/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Stacey Grier report on Form 4 for CLX?

The Form 4 reports an acquisition of 3,364 restricted stock units on 09/16/2025.

How many shares does Stacey Grier beneficially own after the transaction?

The filing shows 23,190 shares beneficially owned following the reported transaction.

What is the vesting schedule for the restricted stock units reported by CLX insider?

The RSUs vest in four equal installments, with one-quarter vesting on October 5 of 2026, 2027, 2028 and 2029.

What price is shown on the Form 4 for the acquired securities?

The Form 4 lists a price of $124.85 associated with the reported acquisition.

Who signed the Form 4 filing and when?

The form was signed By Jinho Joo, Attorney-in-Fact on 09/18/2025.